46,541 Cigna Group $CI Shares Sold by Sanders Capital LLC

Sanders Capital LLC reduced its stake in shares of Cigna Group (NYSE:CI) by 0.5% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,098,076 shares of the health services provider’s stock after selling 46,541 shares during the quarter. Cigna Group comprises approximately 2.7% of Sanders Capital LLC’s portfolio, making the stock its 10th largest holding. Sanders Capital LLC owned about 3.82% of Cigna Group worth $2,744,960,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Evercore Wealth Management LLC increased its position in shares of Cigna Group by 2.8% during the first quarter. Evercore Wealth Management LLC now owns 1,301 shares of the health services provider’s stock worth $347,000 after purchasing an additional 35 shares in the last quarter. Independence Bank of Kentucky boosted its position in shares of Cigna Group by 2.6% in the 2nd quarter. Independence Bank of Kentucky now owns 1,483 shares of the health services provider’s stock valued at $409,000 after purchasing an additional 37 shares during the period. West Family Investments Inc. boosted its position in shares of Cigna Group by 4.2% in the 2nd quarter. West Family Investments Inc. now owns 919 shares of the health services provider’s stock valued at $253,000 after purchasing an additional 37 shares during the period. WPG Advisers LLC boosted its position in shares of Cigna Group by 24.5% in the 1st quarter. WPG Advisers LLC now owns 203 shares of the health services provider’s stock valued at $54,000 after purchasing an additional 40 shares during the period. Finally, Maripau Wealth Management LLC grew its stake in Cigna Group by 4.0% during the 1st quarter. Maripau Wealth Management LLC now owns 1,074 shares of the health services provider’s stock worth $287,000 after buying an additional 41 shares during the last quarter. 86.99% of the stock is owned by hedge funds and other institutional investors.

Key Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Third-quarter adjusted earnings were $7.98 per share, ahead of estimates, while revenue rose 6% to about $73.8 billion and also exceeded consensus. Strength in Cigna Healthcare and a favorable pharmacy benefit mix supported results. Cigna Q3 Earnings and Revenues Beat Estimates
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. Employer medical growth is expected to help offset Cigna’s exit from the ACA individual market. Cigna lifts 2026 outlook
• Positive Sentiment: At its investor event, Cigna outlined a multi-year $3 billion modernization and productivity program, targeting 10%–14% adjusted EPS growth annually and approximately $50 billion in cumulative operating cash flow through 2030. Cigna raises 2026 outlook after strong quarter
• Neutral Sentiment: Analyst views remain supportive: Cantor Fitzgerald reaffirmed Overweight with a $340 target. Guggenheim kept a Buy rating but lowered its target to $347 from $361, tempering the positive signal. Guggenheim ratings
• Negative Sentiment: Despite higher adjusted earnings, reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier. The ACA individual-market exit also brings transition and execution risks, even as employer business growth is expected to offset it. Cigna Group lifts outlook as revenue climbs

Cigna Group Stock Performance

Shares of NYSE CI traded down $7.82 during midday trading on Friday, reaching $293.66. 2,427,984 shares of the company were exchanged, compared to its average volume of 1,441,425. The stock has a market cap of $77.60 billion, a P/E ratio of 12.96, a PEG ratio of 1.00 and a beta of 0.25. Cigna Group has a 1 year low of $255.53 and a 1 year high of $318.05. The stock has a fifty day simple moving average of $285.81 and a 200 day simple moving average of $282.17. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.68.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 EPS for the quarter, beating the consensus estimate of $7.52 by $0.46. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The firm had revenue of $73.79 billion during the quarter, compared to the consensus estimate of $72.64 billion. During the same period in the prior year, the business earned $7.83 EPS. The firm’s revenue was up 5.6% compared to the same quarter last year. On average, research analysts forecast that Cigna Group will post 30.52 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be issued a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $337.00 price target on shares of Cigna Group in a research report on Thursday, October 1st. Wall Street Zen downgraded Cigna Group from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Wells Fargo & Company raised their target price on shares of Cigna Group from $305.00 to $307.00 and gave the stock an “equal weight” rating in a research report on Friday, July 31st. UBS Group reaffirmed a “buy” rating on shares of Cigna Group in a report on Thursday, October 1st. Finally, Piper Sandler reiterated an “overweight” rating on shares of Cigna Group in a research report on Friday, October 23rd. Fourteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $335.70.

Insiders Place Their Bets

In related news, insider Everett Neville sold 617 shares of the company’s stock in a transaction on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the transaction, the insider owned 5,053 shares of the company’s stock, valued at $1,435,304.65. This represents a 10.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company’s stock, valued at approximately $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Cigna Group Profile

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members.

Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

The company serves customers in the United States and select international markets.